Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jayla T. Millender
Observed names:
Jayla Millender,
Jayla T Millender
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
ORCID:
0009-0007-6994-4172
Observed ORCID:
0009-0007-6994-4172
OpenAlex ID:
A5093398902
3BAP1 loss confers ferroptosis resistance to cholangiocarcinoma via TLCD1-mediated mitochondrial membrane phospholipid remodeling
2026
·
Yu Zhao
, Peyton Classon
, et al.
·
The Oncologist
19Aptamer-targeted delivery of siRNA therapeutics for cholangiocarcinoma
2026
·
Brandon A Wilbanks
, Ayano Kabashima
, et al.
·
The Oncologist
18Concurrent ARID1A/PBRM1 loss reorganizes chromatin accessibility through SWI/SNF complex redistribution in Cholangiocarcinoma
2026
·
M Dogukan Aksu
, Jayla T Millender
, et al.
·
The Oncologist
PDF
13Clinical features and transcriptomic landscape of SWI/SNF-mutated biliary tract cancers
2026
·
Jayla Millender
, Muhammed Aksu
, et al.
·
The Oncologist
Abstract 5664: Targeting cholangiocarcinoma with ferroptosis-inducing siRNA-based nanotherapeutics.
2026
·
Peyton Classon
, Danielle Marie Carlson
, et al.
·
Cancer Research
Abstract 2433: BAP1 loss confers ferroptosis resistance to cholangiocarcinoma via TLCD1-mediated membrane phospholipid remodeling
2026
·
Yu Zhao
, Peyton Classon
, et al.
·
Cancer Research
Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinoma
2026
·
Brandon A. Wilbanks
, Ayano Kabashima
, et al.
·
JHEP Reports
The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes
2025
·
Muhammed Dogukan Aksu
, Jayla T. Millender
, et al.
·
Cellular Oncology
PDF
Abstract 2741: Novel murine models of epigenetic dysregulation in SWI/SNF-mutated cholangiocarcinoma
2025
·
Jayla Millender
, Jennifer Tomlinson
, et al.
·
Cancer Research
Abstract 1457: YAP tyrosine phosphorylation regulates lineage commitment in liver tumorigenesis
2025
·
Muhammed D. Aksu
, Jayla T. Millender
, et al.
·
Cancer Research
Abstract A048: Novel murine models of ARID1A and PBRM1-deficient cholangiocarcinoma for preclinical discovery and development
2023
·
Caitlin B. Conboy
, Jennifer L. Tomlinson
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
11
Citation count:
H-index:
I10-index:
Year
Topic
Type
